Semaglutide-Induced Weight Loss: Consequences for Muscle Mass and Functional Outcomes
Introduction: Semaglutide (Ozempic) is a long-acting GLP-1 receptor agonist used in the treatment of type 2 diabetes and obesity. Its potent effects on appetite suppression, delayed gastric emptying, and weight reduction are well documented. Increasing scientific attention has focused on its potent...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Kazimierz Wielki University
2026-02-01
|
| Serie: | Journal of Education, Health and Sport |
| Soggetti: | |
| Accesso online: | https://apcz.umk.pl/JEHS/article/view/68182 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|